DDInter556 DDInter59
Dihydrocodeine is an opioid analgesic used as an alternative or adjunct to codeine to treat moderate to severe pain, severe dyspnea, and cough. It is semi-synthetic, and was developed in Germany in 1908 during an international search to find a more effective antitussive agent to help reduce the spread of airborne infectious diseases such as tuburculosis. It was marketed in 1911.
Alvimopan is a peripherally acting μ opioid antagonist. It is used to avoid postoperative ileus following small or large bowel resection and accelerates the gastrointestinal recovery period.
Dihydrocodeine {u} (Compound) binds {v} (Gene) OPRM1
OPRM1 {u} (Gene) is bound by {v} (Compound) Alvimopan
Dihydrocodeine {u} (Compound) causes {v} (Side Effect) Urinary tract disorder
Urinary tract disorder {u} (Side Effect) is caused by {v} (Compound) Alvimopan
Dihydrocodeine {u} (Compound) resembles {v} (Compound) Nalbuphine
Nalbuphine {u} may lead to a major life threatening interaction when taken with {v} Alvimopan
Dihydrocodeine {u} (Compound) resembles {v} (Compound) Hydromorphone
Hydromorphone {u} may lead to a major life threatening interaction when taken with {v} Alvimopan
Dihydrocodeine {u} (Compound) binds {v} (Gene) OPRM1
OPRM1 {u} (Gene) is bound by {v} (Compound) Anileridine
Anileridine {u} (Compound) resembles {v} (Compound) Alvimopan
Dihydrocodeine {u} (Compound) causes {v} (Side Effect) Urinary tract disorder
Urinary tract disorder {u} (Side Effect) is caused by {v} (Compound) Indinavir
Indinavir {u} (Compound) resembles {v} (Compound) Alvimopan
Dihydrocodeine {u} (Compound) causes {v} (Side Effect) Urinary retention
Urinary retention {u} (Side Effect) is caused by {v} (Compound) Tramadol
Tramadol {u} may lead to a major life threatening interaction when taken with {v} Alvimopan
Dihydrocodeine {u} (Compound) resembles {v} (Compound) Nalbuphine
Nalbuphine {u} (Compound) binds {v} (Gene) OPRD1
OPRD1 {u} (Gene) is bound by {v} (Compound) Alvimopan
Dihydrocodeine {u} (Compound) resembles {v} (Compound) Hydromorphone
Hydromorphone {u} (Compound) binds {v} (Gene) OPRD1
OPRD1 {u} (Gene) is bound by {v} (Compound) Alvimopan
Dihydrocodeine {u} (Compound) resembles {v} (Compound) Morphine
Morphine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Quinapril
Quinapril {u} (Compound) resembles {v} (Compound) Alvimopan
Dihydrocodeine (Compound) binds OPRM1 (Gene) and OPRM1 (Gene) is bound by Alvimopan (Compound)
Dihydrocodeine (Compound) causes Urinary tract disorder (Side Effect) and Urinary tract disorder (Side Effect) is caused by Alvimopan (Compound)
Dihydrocodeine (Compound) resembles Nalbuphine (Compound) and Nalbuphine may lead to a major life threatening interaction when taken with Alvimopan
Dihydrocodeine (Compound) resembles Hydromorphone (Compound) and Hydromorphone may lead to a major life threatening interaction when taken with Alvimopan
Dihydrocodeine (Compound) binds OPRM1 (Gene) and OPRM1 (Gene) is bound by Anileridine (Compound) and Anileridine (Compound) resembles Alvimopan (Compound)
Dihydrocodeine (Compound) causes Urinary tract disorder (Side Effect) and Urinary tract disorder (Side Effect) is caused by Indinavir (Compound) and Indinavir (Compound) resembles Alvimopan (Compound)
Dihydrocodeine (Compound) causes Urinary retention (Side Effect) and Urinary retention (Side Effect) is caused by Tramadol (Compound) and Tramadol may lead to a major life threatening interaction when taken with Alvimopan
Dihydrocodeine (Compound) resembles Nalbuphine (Compound) and Nalbuphine (Compound) binds OPRD1 (Gene) and OPRD1 (Gene) is bound by Alvimopan (Compound)
Dihydrocodeine (Compound) resembles Hydromorphone (Compound) and Hydromorphone (Compound) binds OPRD1 (Gene) and OPRD1 (Gene) is bound by Alvimopan (Compound)
Dihydrocodeine (Compound) resembles Morphine (Compound) and Morphine may cause a moderate interaction that could exacerbate diseases when taken with Quinapril and Quinapril (Compound) resembles Alvimopan (Compound)